ASI 2017*
Chairs: Helen Thomas & Michaela Lucas
Preclinical characterisation of JAK1/JAK2 inhibitors for treatment of type 1 diabetes (#94)
11:00 AM
Developments and needs in allergen specific immunotherapy: targeting grass pollen allergy to mitigate the risk of thunderstorm asthma (#95)
11:25 AM
Induction of paralysed dendritic cells with poor immunogenic function following Systemic Inflammatory Response Syndrome (SIRS) (#96)
11:50 AM
Identification of a type 1 diabetes associated core microbiome driven by disease associated risk alleles (#97)
12:15 PM